How Much Did Novos Raise?
Funding & Key Investors

NOVOS, a data and research-driven longevity company, has secured significant enterprise-level funding, with its most recent capital injection being a major strategic investment. The total funding amount raised by the company stands at $3.2M, underscoring its growth trajectory and market potential in the burgeoning longevity sector. The recent financing round, valued at $3.2M, signals strong investor confidence in NOVOS's innovative approach to nutraceuticals and its commitment to leveraging scientific discoveries for consumer well-being.

What is Novos?

Novos
ManufacturingHealth & Nutrition ProductsBusiness Services

Founded in 2018 and headquartered in New York City, NOVOS operates at the intersection of data science and health innovation. The company specializes in developing well-tested nutraceuticals, grounded in the latest scientific advancements and discoveries in longevity research. NOVOS aims to provide consumers with scientifically validated products designed to enhance healthspan and quality of life, positioning itself as a key player in the preventative health and wellness market.

How much funding has Novos raised?

Novos has raised a total of $3.1M across 1 funding round:

2021

Unspecified

$3.1M

Unspecified (2021): $3.2M with participation from Longevitytech.Fund, Resolute Ventures, Awesome People Ventures, and Arkitekt Ventures

Key Investors in Novos

Longevitytech.Fund

Longevitytech.Fund focuses on global investments in technologies aimed at extending healthy lifespans, supporting innovations that enhance longevity and health outcomes.

Resolute Ventures

Resolute Ventures leads pre-seed and seed funding rounds for determined founders, emphasizing community, mentorship, health, and wellness to support entrepreneurial journeys.

Awesome People Ventures

Awesome People Ventures invests in exceptional pre-seed and seed stage founders, specializing in innovative web3 projects and empowering creators in emerging technology landscapes.

What's next for Novos?

The substantial enterprise-level funding and recent strategic investment indicate that NOVOS is poised for significant scaling and expansion. This capital infusion is likely to accelerate product development, enhance research capabilities, and broaden market reach. Investors backing NOVOS are betting on the company's ability to translate cutting-edge longevity science into tangible consumer products, suggesting a future focused on deepening scientific validation and potentially exploring new therapeutic avenues within the longevity space. The company's strategic direction will likely involve further innovation in nutraceutical formulations and expanding its footprint in the global health and wellness industry.

See full Novos company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Manufacturing industry

ManufacturingTelecommunication Equipment
ManufacturingMedical Devices & Equipment
Industrial Machinery & EquipmentManufacturingAutomotive Parts
ManufacturingTest & Measurement EquipmentIndustrial Machinery & Equipment

Frequently Asked Questions Regarding Novos Financial Insights

What are the most recent funding rounds that Novos has completed, and what were the funding rounds?
Novos has recently completed 1 funding rounds: Unspecified on Oct 4, 2021.
What is the total amount of funding Novos has raised to date?
Novos has raised a total of $3.1M in funding to date.
How many funding rounds has Novos completed?
Novos has completed 1 funding rounds.
How much funding did Novos raise in its most recent funding round?
Novos raised $3.2M in its most recent funding round.
Who are the lead investors in Novos's latest funding round?
The lead investor in Novos's latest funding round was Longevitytech.Fund. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Novos's history?
The largest funding round in Novos's history was $3.2M.
See more information about Novos